The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in european populations: The EPIC-InterAct study

Diabetes Care

Volumn 36, Issue 12, 2013, Pages 3961-3970

  Zamora Ros, Raul ^a,b   Forouhi, Nita G ^a   Sharp, Stephen J ^a   González, Carlos A ^b   Buijsse, Brian ^c   Guevara, Marcela ^d,e   Van Der Schouw, Yvonne T ^f   Amiano, Pilar ^e,g   Boeing, Heiner ^c   Bredsdorff, Lea ^h   Clavel Chapelon, Françoise ^i,j   Fagherazzi, Guy ^i,j   Feskens, Edith J ^k   Franks, Paul W ^l   Grioni, Sara ^m   Katzke, Verena ⁿ   Key, Timothy J ^o   Khaw, Kay Tee ^p   Kühn, Tilman ⁿ   Masala, Giovanna ^q   Mattiello, Amalia ^r   Molina Montes, Esther ^e,s   Nilsson, Peter M ^t   Overvad, Kim ^u   Perquier, Florence ^i,j   Ramon Quiros J ^v   Romieu, Isabelle ^w   Sacerdote, Carlotta ^x   Scalbert, Augustin ^w   Schulze, Matthias ^c   Slimani, Nadia ^w   Spijkerman, Annemieke M W ^y   Tjonneland, Anne ^z   Tormo, Maria Jose ^e,aa,ab   Tumino, Rosario ^ac   Van Der A , Daphne L ^aa   Langenberg, Claudia ^a   Riboli, Elio ^ad   Wareham, Nicholas J ^a   more..

^a MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^h TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

ⁱ CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^j UNIVERSITÉ PARIS SACLAY   (France)

^k WAGENINGEN UNIVERSITY   (Netherlands)

^l LUND UNIVERSITY HOSPITAL   (Sweden)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^q CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^r UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^s ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^t LUND UNIVERSITY   (Sweden)

^u AARHUS UNIVERSITY   (Denmark)

^v PUBLIC HEALTH DIRECTORATE   (Spain)

^w INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^x Human Genetics Foundation   (Italy)

^y NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^z INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^aa DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^ab UNIVERSITY OF MURCIA   (Spain)

^ac Cancer Registry and Histopathology Unit   (Italy)

^ad IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLAVAN DERIVATIVE; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE; FLAVONOID; FLAVONOL DERIVATIVE; GLUCOSE; ISOFLAVONE; LIGNAN; PROANTHOCYANIDIN DERIVATIVE; THEAFLAVIN;

ADULT; ARTICLE; CASE STUDY; COHORT ANALYSIS; DIETARY INTAKE; EUROPE; FEMALE; FOLLOW UP; FOOD COMPOSITION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; PROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SELF REPORT; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; FEEDING BEHAVIOR; HEALTH SURVEY; INCIDENCE; MULTICENTER STUDY;

DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; FLAVONOIDS; FOLLOW-UP STUDIES; FOOD HABITS; HUMANS; INCIDENCE; LIGNANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES;

EID: 84891873486     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0877     Document Type: Article

References (40)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-321
2. Cooper AJ, Forouhi NG, Ye Z, et al.; Inter Act Consortium. Fruit and vegetable intake and type 2 diabetes: EPIC-Inter Act prospective study andmeta-analysis. Eur J Clin Nutr 2012;66:1082-1092
3. Romaguera D, Guevara M, Norat T, et al.; Inter Act Consortium. Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the Inter Act project. Diabetes Care 2011;34:1913-1918
4. Pérez-Jiménez J, Fezeu L, Touvier M, et al. Dietary intake of 337 polyphenols in French adults. AmJ Clin Nutr 2011;93:1220-1228
5. Dembinska-Kiec A, Mykkanen O, Kiec-Wilk B, Mykkanen H. Antioxidant phytochemicals against type 2 diabetes. Br J Nutr 2008;99(E Suppl. 1):ES109-ES117
6. Hanhineva K, Törrönen R, Bondia-Pons I, et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010;11:1365-1402
7. van Dam RM, Naidoo N, Landberg R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr Opin Lipidol 2013;24:25-33
8. Wedick NM, Pan A, Cassidy A, et al. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. AmJ Clin Nutr 2012;95:925-933
9. Song Y, Manson JE, Buring JE, Sesso HD, Liu S. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr 2005;24:376-384
10. Knekt P, Kumpulainen J, Järvinen R, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002;76:560-568
11. Nettleton JA, Harnack LJ, Scrafford CG, Mink PJ, Barraj LM, Jacobs DR Jr. Dietary flavonoids and flavonoid-rich foods are not associated with risk of type 2 diabetes in postmenopausal women. J Nutr 2006; 136:3039-3045
12. Mueller NT, Odegaard AO, Gross MD, et al. Soy intake and risk of type 2 diabetes mellitus in Chinese Singaporeans [corrected]. Eur J Nutr 2012;51:1033-1040
13. Nanri A, Mizoue T, Takahashi Y, et al. Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women. J Nutr 2010;140:580-586
14. Kwon DY, Kim da S, Yang HJ, Park S. The lignan-rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR-g pathways in in vitro and in vivo studies. J Ethnopharmacol 2011; 135:455-462
15. Hano C, Renouard S, Molinié R, et al. Flaxseed (Linumusitatissimum L.) extract as well as (+)-secoisolariciresinol diglucoside and its mammalian derivatives are potent inhibitors of α-amylase activity. Bioorg Med Chem Lett 2013;23:3007-3012
16. Langenberg C, Sharp S, Forouhi NG, et al.; Inter Act Consortium. Design and cohort description of the Inter Act Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 2011;54:2272-2282
17. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5(6B):1113-1124
18. Margetts BM, Pietinen P. European Prospective Investigation into Cancer and Nutrition: validity studies on dietary assessment methods. Int J Epidemiol 1997; 26(Suppl. 1):S1-S5
19. Slimani N, Deharveng G, Unwin I, et al. The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 2007;61:1037-1056
20. Zamora-Ros R, Knaze V, Luján-Barroso L, et al. Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort. Eur J Clin Nutr 2012;66:932-941
21. Zamora-Ros R, Knaze V, Luján-Barroso L, et al. Differences in dietary intakes, food sources and determinants of total flavonoids between Mediterranean and non-Mediterranean countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr 2013;109:1498-1507
22. U.S. Departament of Agriculture. USDA Database for the Flavonoid Content of Selected Foods. Beltsville, MD, U.S. Department of Agriculture, 2007
23. Neveu V, Perez-Jiménez J, Vos F, et al. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford) 2010;2010:bap024
24. Ward HA, Kuhnle GG, Mulligan AA, Lentjes MA, Luben RN, Khaw KT. Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr 2010; 91:440-448
25. Crozier A, Lean MEJ, McDonald MS, Black C. Quantitative analysis of the flavonoid content of commercial tomatoes, onions, lettuces, and celery. J Agric Food Chem 1997;45:590-595
26. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003;6:407-413
27. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 1999;52:1165-1172
28. Inter Act Consortium. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-Inter Act study. Diabetologia 2013;56:60-69
29. Langenberg C, Sharp SJ, Schulze MB, et al.; Inter Act Consortium. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPICInter Act case-cohort study. PLoSMed 2012; 9:e1001230
30. Lee SA, Wen W, Xiang YB, et al. Assessment of dietary isoflavone intake among middle-aged Chinese men. J Nutr 2007; 137:1011-1016
31. van der Schouw YT, Sampson L, Willett WC, Rimm EB. The usual intake of lignans but not that of isoflavones may be related to cardiovascular risk factors in U.S. men. J Nutr 2005;135:260-266
32. Beulens JW, van der Schouw YT, Bergmann MM, et al.; Inter Act Consortium. Alcohol consumption and risk of type 2 diabetes in European men and women: influence of beverage type and body size The EPICInter Act study. J Intern Med 2012;272:358-370
33. Inter Act Consortium. Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-Inter Act case-cohort study. PLoS One 2012;7:e36910
34. Rubilar M, Jara C, Poo Y, et al. Extracts of Maqui (Aristotelia chilensis) and Murta (Ugnimolinae Turcz.): sources of antioxidant compounds and a-Glucosidase/a-Amylase inhibitors. J Agric Food Chem 2011;59: 1630-1637
35. Kwon O, Eck P, Chen S, et al. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J 2007;21:366-377
36. Takikawa M, Inoue S, Horio F, Tsuda T. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J Nutr 2010;140:527-533
37. Han MK. Epigallocatechin gallate, a constituent of green tea, suppresses cytokineinduced pancreatic beta-cell damage. Exp Mol Med 2003;35:136-139
38. Matsuda T, Ferreri K, Todorov I, et al. Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. Endocrinology 2005;146:175-185
39. Skeie G, Braaten T, Hjartåker A, et al. Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr 2009;63(Suppl. 4):S226-S238
40. Zamora-Ros R, Rabassa M, Llorach R, González CA, Andres-Lacueva C. Application of dietary phenolic biomarkers in epidemiology: past, present, and future. J Agric Food Chem. 22 February 2012 [Epub ahead of print]